Diabetes insipidus pathophysiology: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Diabetes insipidus}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{WH}} {{WS}} Category:Disease Category:Endocrinology Category:Nephrology")
 
No edit summary
Line 3: Line 3:
{{CMG}}
{{CMG}}
==Overview==
==Overview==
==Pathophysiology==
* [[Diabetes Insipidus|Diabetes insipidus]] (DI) is an endocrine disorder involving deficient production or lack of effective action of pituitary antidiuretic hormone (ADH, AVP, arginine vaopressin)
* DI is characterized by chronic excretion of very large amounts of urine
* DI is coupled with [[Ddx:Dehydration|dehydration]] and excessive thirst
Electrolyte and volume [[homeostasis]] is a complex mechanism that balances the body's requirements for [[blood pressure]] and the main electrolytes [[sodium]] and [[potassium]]. In general, electrolyte regulation precedes volume regulation. When the volume is severely depleted, however, the body will retain water at the expense of deranging electrolyte levels.
The regulation of urine production occurs in the [[hypothalamus]], which produces [[antidiuretic hormone]] (ADH or vasopressin) in the [[Supraoptic nucleus|supraoptic]] and [[Paraventricular nucleus|paraventricular]] nuclei.  After synthesis, the hormone is transported in neurosecretory granules down the axon of the hypothalamic neuron to the posterior lobe of the [[pituitary gland]] where it is stored for later release. In addition, the hypothalamus regulates the sensation of thirst in the [[ventromedial nucleus]] by sensing increases in serum osmolarity and relaying this information to the [[Cerebral cortex|cortex]].
The main effector organ for [[body water|fluid]] homeostasis is the [[kidney]]. ADH acts by increasing water permeability in the [[collecting ducts]], specifically it acts on proteins called [[aquaporin]]s which open to allow water into the collecting duct cells. This increase in permeability allows for reabsorption of water into the bloodstream, thus concentrating the urine.
There are several forms of DI:
* ''Central'' diabetes insipidus is due to damage to the hypothalamus or pituitary due to a [[tumor]], [[cerebrovascular accident|stroke]], [[neurosurgery]] or some rather rare causes (which include [[hemochromatosis]], [[sarcoidosis]], [[histiocytosis]], diseases that can form masses in the vicinity like a [[tuberculoma]] or [[syphilis]] and some [[genetic disorder]]s). If the hypothalamus is damaged, the feeling of thirst may be completely absent.
* ''Nephrogenic'' diabetes insipidus is due to the inability of the kidney to respond normally to ADH. There are hereditary causes (90% are due to mutations of the ADH V2 receptor, and 10% mutations of the [[aquaporin#AQP2|aquaporin 2]] water channel), but these are rare (incidence is around 4 per million live births). Most are male, because V2 receptor mutations are x-linked recessive defects. More common are acquired forms of NDI, which occur as a side-effect to some [[medication]]s (such as [[lithium citrate]] and [[amphotericin B]]), as well as in [[polycystic kidney disease]] (PKD) and [[sickle-cell disease]], and electrolyte disturbances such as hypokalaemia and hypercalcaemia. In some cases, no cause is found.
* ''Dipsogenic'' DI is due to a defect or damage to the thirst mechanism, which is located in the hypothalamus. This defect results in an abnormal increase in thirst and fluid intake that suppresses ADH secretion and increases urine output. Desmopressin is ineffective, and can lead to fluid overload as the thirst remains.
* ''Gestational'' DI only occurs during [[pregnancy]]. While all pregnant women produce ''vasopressinase'' in the [[placenta]], which breaks down ADH, this can assume extreme forms in GDI. Most cases of gestational DI can be treated with desmopressin. In rare cases, however, an abnormality in the thirst mechanism causes gestational DI, and [[desmopressin]] should not be used.
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 03:06, 21 September 2012

Diabetes insipidus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Diabetes insipidus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT scan

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Diabetes insipidus pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Diabetes insipidus pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Diabetes insipidus pathophysiology

CDC on Diabetes insipidus pathophysiology

Diabetes insipidus pathophysiology in the news

Blogs on Diabetes insipidus pathophysiology

Directions to Hospitals Treating Diabetes insipidus

Risk calculators and risk factors for Diabetes insipidus pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

  • Diabetes insipidus (DI) is an endocrine disorder involving deficient production or lack of effective action of pituitary antidiuretic hormone (ADH, AVP, arginine vaopressin)
  • DI is characterized by chronic excretion of very large amounts of urine
  • DI is coupled with dehydration and excessive thirst

Electrolyte and volume homeostasis is a complex mechanism that balances the body's requirements for blood pressure and the main electrolytes sodium and potassium. In general, electrolyte regulation precedes volume regulation. When the volume is severely depleted, however, the body will retain water at the expense of deranging electrolyte levels. The regulation of urine production occurs in the hypothalamus, which produces antidiuretic hormone (ADH or vasopressin) in the supraoptic and paraventricular nuclei. After synthesis, the hormone is transported in neurosecretory granules down the axon of the hypothalamic neuron to the posterior lobe of the pituitary gland where it is stored for later release. In addition, the hypothalamus regulates the sensation of thirst in the ventromedial nucleus by sensing increases in serum osmolarity and relaying this information to the cortex. The main effector organ for fluid homeostasis is the kidney. ADH acts by increasing water permeability in the collecting ducts, specifically it acts on proteins called aquaporins which open to allow water into the collecting duct cells. This increase in permeability allows for reabsorption of water into the bloodstream, thus concentrating the urine. There are several forms of DI:

  • Central diabetes insipidus is due to damage to the hypothalamus or pituitary due to a tumor, stroke, neurosurgery or some rather rare causes (which include hemochromatosis, sarcoidosis, histiocytosis, diseases that can form masses in the vicinity like a tuberculoma or syphilis and some genetic disorders). If the hypothalamus is damaged, the feeling of thirst may be completely absent.
  • Nephrogenic diabetes insipidus is due to the inability of the kidney to respond normally to ADH. There are hereditary causes (90% are due to mutations of the ADH V2 receptor, and 10% mutations of the aquaporin 2 water channel), but these are rare (incidence is around 4 per million live births). Most are male, because V2 receptor mutations are x-linked recessive defects. More common are acquired forms of NDI, which occur as a side-effect to some medications (such as lithium citrate and amphotericin B), as well as in polycystic kidney disease (PKD) and sickle-cell disease, and electrolyte disturbances such as hypokalaemia and hypercalcaemia. In some cases, no cause is found.
  • Dipsogenic DI is due to a defect or damage to the thirst mechanism, which is located in the hypothalamus. This defect results in an abnormal increase in thirst and fluid intake that suppresses ADH secretion and increases urine output. Desmopressin is ineffective, and can lead to fluid overload as the thirst remains.
  • Gestational DI only occurs during pregnancy. While all pregnant women produce vasopressinase in the placenta, which breaks down ADH, this can assume extreme forms in GDI. Most cases of gestational DI can be treated with desmopressin. In rare cases, however, an abnormality in the thirst mechanism causes gestational DI, and desmopressin should not be used.

References

Template:WH Template:WS